Workflow
Relative Strength Index (RSI)
icon
Search documents
Snowflake Melts Resistance: Can Q1 Earnings Spark A Fresh Flurry Of Gains?
Benzinga· 2025-05-21 18:30
Snowflake Inc. SNOW is skating into its first quarter earnings report with momentum on its side and charts flashing bright. The company is set to report after market hours today, with Wall Street expecting earnings per share of 21 cents and $1.01 billion in revenue.The stock is up 10.84% over the past year, down 14.50% year-to-date, but it has caught fire lately – rallying 31.64% in just the past month. Let's dig into what the charts are signaling ahead of the print, and how analysts see things playing out. ...
After Plunging -15.69% in 4 Weeks, Here's Why the Trend Might Reverse for Inogen (INGN)
ZACKS· 2025-05-16 14:35
Inogen (INGN) has been on a downward spiral lately with significant selling pressure. After declining 15.7% over the past four weeks, the stock looks well positioned for a trend reversal as it is now in oversold territory and there is strong agreement among Wall Street analysts that the company will report better earnings than they predicted earlier.How to Determine if a Stock is OversoldWe use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting whether a stock is ...
Down -29.72% in 4 Weeks, Here's Why Surrozen (SRZN) Looks Ripe for a Turnaround
ZACKS· 2025-05-16 14:35
Surrozen, Inc. (SRZN) has been beaten down lately with too much selling pressure. While the stock has lost 29.7% over the past four weeks, there is light at the end of the tunnel as it is now in oversold territory and Wall Street analysts expect the company to report better earnings than they predicted earlier.Guide to Identifying Oversold StocksWe use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting whether a stock is oversold. This is a momentum oscillator th ...
Allogene Therapeutics (ALLO) Loses -31.94% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
ZACKS· 2025-05-15 14:36
Core Viewpoint - Allogene Therapeutics (ALLO) has experienced a significant decline of 31.9% over the past four weeks, but it is now in oversold territory, suggesting a potential turnaround as analysts expect better earnings than previously predicted [1]. Group 1: Stock Performance and Technical Indicators - ALLO's stock has been under heavy selling pressure, leading to an RSI reading of 25.87, indicating it is oversold [5]. - The Relative Strength Index (RSI) is a momentum oscillator that helps identify oversold conditions when the reading falls below 30 [2]. - Stocks oscillate between overbought and oversold states, and an oversold condition may present entry opportunities for investors anticipating a rebound [3]. Group 2: Analyst Sentiment and Earnings Estimates - There is a strong consensus among sell-side analysts to raise earnings estimates for ALLO, resulting in a 0.4% increase in the consensus EPS estimate over the last 30 days [7]. - An upward trend in earnings estimate revisions typically correlates with price appreciation in the near term [7]. - ALLO holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate trends and EPS surprises, indicating a strong potential for a turnaround [8].
After Plunging -5.25% in 4 Weeks, Here's Why the Trend Might Reverse for New Jersey Resources (NJR)
ZACKS· 2025-05-14 14:45
A downtrend has been apparent in New Jersey Resources (NJR) lately with too much selling pressure. The stock has declined 5.3% over the past four weeks. However, given the fact that it is now in oversold territory and Wall Street analysts are majorly in agreement about the company's ability to report better earnings than they predicted earlier, the stock could be due for a turnaround.How to Determine if a Stock is OversoldWe use Relative Strength Index (RSI), one of the most commonly used technical indicato ...
Pharma Fire Sale: 3 Stocks the RSI Says You Shouldn't Ignore
MarketBeat· 2025-05-14 12:30
Investors searching for high-quality opportunities in the pharmaceutical space should keep a close eye on stocks trading at extremely oversold levels. One of the most popular ways to measure this is through the Relative Strength Index (RSI), a technical momentum indicator that signals when a stock may be due for a rebound. An RSI below 30 suggests a stock is extremely oversold and could be primed for a bounce, especially if sentiment is showing signs of turning or if the stock has retained analyst support.  ...
Down -30.54% in 4 Weeks, Here's Why Sera Prognostics (SERA) Looks Ripe for a Turnaround
ZACKS· 2025-05-13 14:35
Sera Prognostics, Inc. (SERA) has been beaten down lately with too much selling pressure. While the stock has lost 30.5% over the past four weeks, there is light at the end of the tunnel as it is now in oversold territory and Wall Street analysts expect the company to report better earnings than they predicted earlier.Guide to Identifying Oversold StocksWe use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting whether a stock is oversold. This is a momentum oscil ...
Down -57.05% in 4 Weeks, Here's Why You Should You Buy the Dip in AZUL (AZUL)
ZACKS· 2025-05-12 14:35
AZUL (AZUL) has been on a downward spiral lately with significant selling pressure. After declining 57.1% over the past four weeks, the stock looks well positioned for a trend reversal as it is now in oversold territory and there is strong agreement among Wall Street analysts that the company will report better earnings than they predicted earlier.Guide to Identifying Oversold StocksWe use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting whether a stock is over ...
Down -20.26% in 4 Weeks, Here's Why LifeStance Health (LFST) Looks Ripe for a Turnaround
ZACKS· 2025-05-08 14:35
LifeStance Health Group (LFST) has been on a downward spiral lately with significant selling pressure. After declining 20.3% over the past four weeks, the stock looks well positioned for a trend reversal as it is now in oversold territory and there is strong agreement among Wall Street analysts that the company will report better earnings than they predicted earlier.How to Determine if a Stock is OversoldWe use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting w ...
Rideshare Stock Slips on Q1 Revenue Miss
Schaeffers Investment Research· 2025-05-07 15:17
Rideshare stock Uber Technologies Inc (NYSE:UBER) is down 1.4% at $84.65 at last glance, after the company's mixed first-quarter results. Earnings of 83 cent per share beat the Zacks Research estimate of 51 cents per share, while revenue of $11.53 billion slightly missed expectations. Today's drop has UBER looking to snap a three-day win streak. The stock hovered around $86.50 at its highs during the last two sessions, but failed to extend its Oct. 11 record high of $87. Today, former pressure at the $80 le ...